Correlation Between Central Asia and ImmuPharma PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Central Asia and ImmuPharma PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Central Asia and ImmuPharma PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Central Asia Metals and ImmuPharma PLC, you can compare the effects of market volatilities on Central Asia and ImmuPharma PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Central Asia with a short position of ImmuPharma PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Central Asia and ImmuPharma PLC.

Diversification Opportunities for Central Asia and ImmuPharma PLC

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Central and ImmuPharma is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Central Asia Metals and ImmuPharma PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ImmuPharma PLC and Central Asia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Central Asia Metals are associated (or correlated) with ImmuPharma PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ImmuPharma PLC has no effect on the direction of Central Asia i.e., Central Asia and ImmuPharma PLC go up and down completely randomly.

Pair Corralation between Central Asia and ImmuPharma PLC

Assuming the 90 days trading horizon Central Asia Metals is expected to generate 0.25 times more return on investment than ImmuPharma PLC. However, Central Asia Metals is 4.05 times less risky than ImmuPharma PLC. It trades about 0.03 of its potential returns per unit of risk. ImmuPharma PLC is currently generating about -0.3 per unit of risk. If you would invest  16,660  in Central Asia Metals on September 12, 2024 and sell it today you would earn a total of  140.00  from holding Central Asia Metals or generate 0.84% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.65%
ValuesDaily Returns

Central Asia Metals  vs.  ImmuPharma PLC

 Performance 
       Timeline  
Central Asia Metals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Central Asia Metals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Central Asia is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
ImmuPharma PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ImmuPharma PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Central Asia and ImmuPharma PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Central Asia and ImmuPharma PLC

The main advantage of trading using opposite Central Asia and ImmuPharma PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Central Asia position performs unexpectedly, ImmuPharma PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ImmuPharma PLC will offset losses from the drop in ImmuPharma PLC's long position.
The idea behind Central Asia Metals and ImmuPharma PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume